Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.

Martin LW, Robson CL, Watts AM, Gray AR, Wainwright CE, Bell SC, Ramsay KA, Kidd TJ, Reid DW, Brockway B, Lamont IL.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01789-18. doi: 10.1128/AAC.01789-18. Print 2018 Nov.

PMID:
30201819
2.

Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung.

Nguyen AT, O'Neill MJ, Watts AM, Robson CL, Lamont IL, Wilks A, Oglesby-Sherrouse AG.

J Bacteriol. 2014 Jun;196(12):2265-76. doi: 10.1128/JB.01491-14. Epub 2014 Apr 11.

3.

Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.

Kong L, Sheppard NC, Stewart-Jones GBE, Robson CL, Chen H, Xu X, Krashias G, Bonomelli C, Scanlan CN, Kwong PD, Jeffs SA, Jones IM, Sattentau QJ.

J Mol Biol. 2010 Oct 15;403(1):131-147. doi: 10.1016/j.jmb.2010.08.033. Epub 2010 Aug 25.

4.

Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.

Romer D, Brighty DW, Robson CL, Sattentau QJ.

Antimicrob Agents Chemother. 2009 Feb;53(2):678-87. doi: 10.1128/AAC.01550-07. Epub 2008 Dec 1.

5.

Isolation and partial characterization of the Streptococcus mutans type AII lantibiotic mutacin K8.

Robson CL, Wescombe PA, Klesse NA, Tagg JR.

Microbiology. 2007 May;153(Pt 5):1631-41.

PMID:
17464078

Supplemental Content

Loading ...
Support Center